StockData

Goldenwell Biotech, Inc. (GWLL) stock

GWLLOTCFood and Kindred ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.65+0.05 (+8.33%)

Close on Oct 19, 2026Market cap $64.35MP/E –Yield –

Goldenwell Biotech revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Goldenwell Biotech's revenue for the twelve months ending Jun 30, 2026 was $55. For fiscal 2025 it was $55, down 60.4% from the year before. The highest annual figure on record is $47.80K in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$55-60.4%
FY2024Dec 31, 2024$139-92.4%
FY2023Dec 31, 2023$1.84K-96.2%
FY2022Dec 31, 2022$47.80K+199.4%
FY2021Dec 31, 2021$15.97K–
FY2020Dec 31, 2020$0–
FY2019Dec 31, 2019$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0–
Q1 FY2026Mar 31, 2026$0–
Q4 FY2025Dec 31, 2025$55–
Q3 FY2025Sep 30, 2025$0–
Q2 FY2025Jun 30, 2025$0-100.0%
Q1 FY2025Mar 31, 2025$0–
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$139-49.6%
Q1 FY2024Mar 31, 2024$0-100.0%
Q4 FY2023Dec 31, 2023$260–
Q3 FY2023Sep 30, 2023$382-99.1%
Q2 FY2023Jun 30, 2023$276-92.6%
Q1 FY2023Mar 31, 2023$1.42K+258.2%
Q4 FY2022Dec 31, 2022$0-100.0%
Q3 FY2022Sep 30, 2022$43.69K+259.1%
Q2 FY2022Jun 30, 2022$3.71K+235.7%
Q1 FY2022Mar 31, 2022$397–
Q4 FY2021Dec 31, 2021$4.91K–
Q3 FY2021Sep 30, 2021$12.17K–
Q2 FY2021Jun 30, 2021$1.11K–
Q1 FY2021Mar 31, 2021$0–
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$0–
Q1 FY2020Mar 31, 2020$0–
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$0–

More Goldenwell Biotech figures

See a number that looks wrong?